BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Nicoletti A, Ponziani FR, Biolato M, Valenza V, Marrone G, Sganga G, Gasbarrini A, Miele L, Grieco A. Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation. World J Gastroenterol 2019; 25(33): 4814-4834 [PMID: 31543676 DOI: 10.3748/wjg.v25.i33.4814]
URL: https://www.wjgnet.com/1948-5182/full/v25/i33/4814.htm
Number Citing Articles
1
Célia Chamignon, Geoffroy Mallaret, Julie Rivière, Marthe Vilotte, Sead Chadi, Alejandra de Moreno de LeBlanc, Jean Guy LeBlanc, Frédéric Antonio Carvalho, Marco Pane, Pierre-Yves Mousset, Philippe Langella, Sophie Lafay, Luis G. Bermúdez-Humarán. Beneficial Effects of Lactobacilli Species on Intestinal Homeostasis in Low-Grade Inflammation and Stress Rodent Models and Their Implication in the Modulation of the Adhesive Junctional ComplexBiomolecules 2023; 13(9): 1295 doi: 10.3390/biom13091295
2
Ali Riza Caliskan, Mehmet Gul, Ismet Yılmaz, Baris Otlu, Nuray Uremis, Muhammed Mehdi Uremis, Ilkay Kilicaslan, Semir Gul, Deniz Tikici, Osman Saglam, Muhammed Yalcin, Ulvi Demirel, Murat Harputluoglu. Effects of larazotide acetate, a tight junction regulator, on the liver and intestinal damage in acute liver failure in ratsHuman & Experimental Toxicology 2021; 40(12_suppl): S693 doi: 10.1177/09603271211058882
3
Yi Yuan, Xiyang Wang, Shun Huang, Hao Wang, Guoming Shen. Low-level inflammation, immunity, and brain-gut axis in IBS: unraveling the complex relationshipsGut Microbes 2023; 15(2) doi: 10.1080/19490976.2023.2263209
4
Dmitry Victorovich Garbuzenko. Pathophysiological mechanisms of hepatic stellate cells activation in liver fibrosis World Journal of Clinical Cases 2022; 10(12): 3662-3676 doi: 10.12998/wjcc.v10.i12.3662
5
Jiahao Huang, Xinbo Sun, Yang Wang, Jianlong Su, Guangzhe Li, Xu Wang, Yuning Yang, Yuxuan Zhang, Bangjian Li, Guanyi Zhang, Jinrong Li, Jing Du, Roopa Hebbandi Nanjundappa, Channakeshava Sokke Umeshappa, Kun Shao. Biological interactions of polystyrene nanoplastics: Their cytotoxic and immunotoxic effects on the hepatic and enteric systemsEcotoxicology and Environmental Safety 2023; 264: 115447 doi: 10.1016/j.ecoenv.2023.115447
6
Yiwei Dong, Qianqian Cai, Lisheng Fu, Haojie Liu, Mingzhe Ma, Xingzhong Wu, Tao Huang. Study of the G Protein Nucleolar 2 Value in Liver Hepatocellular Carcinoma Treatment and PrognosisBioMed Research International 2021; 2021: 1 doi: 10.1155/2021/4873678
7
Pavlo Petakh, Valentyn Oksenych, Iryna Kamyshna, Iryna Boisak, Katerina Lyubomirskaya, Oleksandr Kamyshnyi. Exploring the complex interplay: gut microbiome, stress, and leptospirosisFrontiers in Microbiology 2024; 15 doi: 10.3389/fmicb.2024.1345684
8
Victor Sánchez, Annette Brandt, Cheng Jun Jin, Dragana Rajcic, Anna Janina Engstler, Finn Jung, Anika Nier, Anja Baumann, Ina Bergheim. Fortifying Butterfat with Soybean Oil Attenuates the Onset of Diet-Induced Non-Alcoholic Steatohepatitis and Glucose IntoleranceNutrients 2021; 13(3): 959 doi: 10.3390/nu13030959
9
Silvia Lopez-Escalera, Mari L. Lund, Gerben D. A. Hermes, Béatrice S.-Y. Choi, Kei Sakamoto, Anja Wellejus. In Vitro Screening for Probiotic Properties of Lactobacillus and Bifidobacterium Strains in Assays Relevant for Non-Alcoholic Fatty Liver Disease PreventionNutrients 2023; 15(10): 2361 doi: 10.3390/nu15102361
10
Alessio Ardizzone, Marika Lanza, Giovanna Casili, Michela Campolo, Irene Paterniti, Salvatore Cuzzocrea, Emanuela Esposito. Efficacy of a Novel Therapeutic, Based on Natural Ingredients and Probiotics, in a Murine Model of Multiple Food Intolerance and MaldigestionNutrients 2022; 14(11): 2251 doi: 10.3390/nu14112251
11
Fiorella D’Onofrio, Giorgia Renga, Matteo Puccetti, Marilena Pariano, Marina Maria Bellet, Ilaria Santarelli, Claudia Stincardini, Paolo Mosci, Maurizio Ricci, Stefano Giovagnoli, Claudio Costantini, Luigina Romani. Indole-3-Carboxaldehyde Restores Gut Mucosal Integrity and Protects from Liver Fibrosis in Murine Sclerosing CholangitisCells 2021; 10(7): 1622 doi: 10.3390/cells10071622
12
Xu Zhang, Jing Chen, Shengmin Zhou, Yuanrong Jiang, Yong Wang, Ying Li. The effect of flaxseed oil after deep frying on lipid metabolism and gut barrier homeostasisFood Research International 2024; 175: 113728 doi: 10.1016/j.foodres.2023.113728
13
Maria Cerreto, Francesco Santopaolo, Antonio Gasbarrini, Maurizio Pompili, Francesca Ponziani. Bariatric Surgery and Liver Disease: General Considerations and Role of the Gut–Liver AxisNutrients 2021; 13(8): 2649 doi: 10.3390/nu13082649
14
Tamilmani Periyasamy, V. V. Sathibabu Uddandrao, Chandrasekaran Ponnusamy, Saravanan Ganapathy, Sethumathi Ponnusamy Pudhupalayam, Sengottuvelu Singaravel, Ponmurugan Ponnusamy, Jagadeesan Ramasamy, Kalaivani Aiyasamy, Vadivukkarasi Sasikumar. Linalool Mitigated High-Fat Diet–Induced Non-alcoholic Fatty Liver Disease by Regulating the Intestinal-Hepatic Axis via TGF-β/NF-kB/TLR4/ZO-1 PathwayRevista Brasileira de Farmacognosia 2023; 33(3): 617 doi: 10.1007/s43450-023-00395-6
15
Yang Ye, Yanan Liu, Kejun Cheng, Zufang Wu, Peng Zhang, Xin Zhang. Effects of Intestinal Flora on Irritable Bowel Syndrome and Therapeutic Significance of PolysaccharidesFrontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.810453
16
Ji-Shuai Wang, Jin-Chun Liu. Intestinal microbiota in the treatment of metabolically associated fatty liver diseaseWorld Journal of Clinical Cases 2022; 10(31): 11240-11251 doi: 10.12998/wjcc.v10.i31.11240
17
Andrei Dumitru, Elena Matei, Georgeta Camelia Cozaru, Anca Chisoi, Luana Alexandrescu, Răzvan Cătălin Popescu, Mihaela Pundiche Butcaru, Eugen Dumitru, Sorin Rugină, Cristina Tocia. Endotoxin Inflammatory Action on Cells by Dysregulated-Immunological-Barrier-Linked ROS-Apoptosis Mechanisms in Gut–Liver AxisInternational Journal of Molecular Sciences 2024; 25(5): 2472 doi: 10.3390/ijms25052472
18
Irina Efremova, Roman Maslennikov, Elena Poluektova, Oleg Medvedev, Anna Kudryavtseva, George Krasnov, Maria Fedorova, Filipp Romanikhin, Maria Zharkova, Oxana Zolnikova, Gyunay Bagieva, Vladimir Ivashkin. Presepsin as a biomarker of bacterial translocation and an indicator for the prescription of probiotics in cirrhosisWorld Journal of Hepatology 2024; 16(5): 822-831 doi: 10.4254/wjh.v16.i5.822
19
Luca Miele, Maria Adele Alberelli, Maurizio Martini, Antonio Liguori, Giuseppe Marrone, Alessandra Cocomazzi, Fabio Maria Vecchio, Raffaele Landolfi, Antonio Gasbarrini, Antonio Grieco, Erica De Candia. Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of plateletsTranslational Research 2021; 231: 24 doi: 10.1016/j.trsl.2020.11.003
20
D. V. Garbuzenko. Pathophysiological Prerequisites and Therapeutic Potential of Fecal Microbiota Transplantation in Severe Alcoholic HepatitisThe Russian Archives of Internal Medicine 2022; 12(5): 352 doi: 10.20514/2226-6704-2022-12-5-352-362
21
Indira Bhavsar‐Burke, Claire L. Jansson‐Knodell, Ashley C. Gilmore, David W. Crabb. Review article: the role of nutrition in alcohol‐associated liver diseaseAlimentary Pharmacology & Therapeutics 2021; 53(12): 1268 doi: 10.1111/apt.16380
22
Federica Riva, Susanna Draghi, Alessia Inglesi, Joel Filipe, Paola Cremonesi, Antonio Lavazza, Patrizia Cavadini, Daniele Vigo, Stella Agradi, Laura Menchetti, Alessia Di Giancamillo, Lucia Aidos, Silvia Clotilde Modina, Nour Elhouda Fehri, Grazia Pastorelli, Valentina Serra, Claudia Maria Balzaretti, Marta Castrica, Marco Severgnini, Gabriele Brecchia, Giulio Curone. Bovine Colostrum Supplementation in Rabbit Diet Modulates Gene Expression of Cytokines, Gut–Vascular Barrier, and Red-Ox-Related Molecules in the Gut WallAnimals 2024; 14(5): 800 doi: 10.3390/ani14050800
23
Maria Consiglia Bragazzi, Rosanna Venere, Anthony Vignone, Domenico Alvaro, Vincenzo Cardinale. Role of the Gut–Liver Axis in the Pathobiology of Cholangiopathies: Basic and Clinical EvidenceInternational Journal of Molecular Sciences 2023; 24(7): 6660 doi: 10.3390/ijms24076660
24
Kevin De Muynck, Bart Vanderborght, Hans Van Vlierberghe, Lindsey Devisscher. The Gut–Liver Axis in Chronic Liver Disease: A Macrophage PerspectiveCells 2021; 10(11): 2959 doi: 10.3390/cells10112959
25
Khadija A.M. Glal, Sahar M. El-Haggar, Sherief M. Abdel-Salam, Tarek M. Mostafa. Allopurinol Prevents Cirrhosis-Related Complications: A Quadruple Blind Placebo-Controlled TrialThe American Journal of Medicine 2024; 137(1): 55 doi: 10.1016/j.amjmed.2023.09.016
26
Changrui Long, Xiaoyan Zhou, Fan Xia, Benjie Zhou. Intestinal Barrier Dysfunction and Gut Microbiota in Non-Alcoholic Fatty Liver Disease: Assessment, Mechanisms, and Therapeutic ConsiderationsBiology 2024; 13(4): 243 doi: 10.3390/biology13040243
27
Anatoli M. Pershko, I. I. Yarovenko, V. A. Pershko. Metabolic basis for substantiation of nutrition therapy in chronic liver diseasesExperimental and Clinical Gastroenterology 2022; (7): 185 doi: 10.31146/1682-8658-ecg-203-7-185-191
28
Valeria Maccauro, Carlo Airola, Francesco Santopaolo, Antonio Gasbarrini, Francesca Romana Ponziani, Maurizio Pompili. Gut Microbiota and Infectious Complications in Advanced Chronic Liver Disease: Focus on Spontaneous Bacterial PeritonitisLife 2023; 13(4): 991 doi: 10.3390/life13040991
29
Raz Abdulqadir, Jessica Engers, Rana Al-Sadi. Role of Bifidobacterium in Modulating the Intestinal Epithelial Tight Junction Barrier: Current Knowledge and PerspectivesCurrent Developments in Nutrition 2023; 7(12): 102026 doi: 10.1016/j.cdnut.2023.102026
30
Giulia Gibiino, Alessandro Sartini, Stefano Gitto, Cecilia Binda, Monica Sbrancia, Chiara Coluccio, Vittorio Sambri, Carlo Fabbri. The Other Side of Malnutrition in Inflammatory Bowel Disease (IBD): Non-Alcoholic Fatty Liver DiseaseNutrients 2021; 13(8): 2772 doi: 10.3390/nu13082772
31
Manvi Sharma, Itika Arora, Trygve O. Tollefsbol. Comprehensive Gut Microbiota2022; : 223 doi: 10.1016/B978-0-12-819265-8.00007-3
32
András Zóka, Béla Kádár, Eszter Vad. Fertőzésekhez kapcsolódó immunológiai jelenségek: a szürkezóna jelentőségeOrvosi Hetilap 2021; 162(38): 1526 doi: 10.1556/650.2021.32222
33
Marta Melis, Xiao-Han Tang, Steven E. Trasino, Lorraine J. Gudas. Retinoids in the Pathogenesis and Treatment of Liver DiseasesNutrients 2022; 14(7): 1456 doi: 10.3390/nu14071456
34
Ahmed Mohamed ElGhandour, Essam Mohammed Bayoumy, Moataz Mohammed Sayed, Moheb Sharaby Eskandaros, Abdelmomen Momen Mohamed Emam, Nahla Mohamed Teama, Manal Sabry Mohamed, Sonya Ahmed El-Gaaly. Value of zonulin as a diagnostic and prognostic marker in different degrees of nonalcoholic fatty liver diseaseEgyptian Liver Journal 2024; 14(1) doi: 10.1186/s43066-024-00351-6
35
Yin Zhu, Xiaozhi Wang, Lujian Zhu, Yulu Tu, Wanting Chen, Lingwen Gong, Tongtong Pan, Hongwei Lin, Jing Lin, Huiling Sun, Yuli Ge, Li Wei, Yu Guo, Caide Lu, Yongping Chen, Lanman Xu. Lactobacillus rhamnosus GG combined with inosine ameliorates alcohol-induced liver injury through regulation of intestinal barrier and Treg/Th1 cellsToxicology and Applied Pharmacology 2022; 439: 115923 doi: 10.1016/j.taap.2022.115923
36
Roman Maslennikov, Vladimir Ivashkin, Irina Efremova, Elena Poluektova, Elena Shirokova. Probiotics in hepatology: An updateWorld Journal of Hepatology 2021; 13(9): 1154-1166 doi: 10.4254/wjh.v13.i9.1154
37
S. N. Mekhtiyev, O. A. Mekhtiyeva, O. M. Berko, A. M. Kolodkin. Role of increased intestinal permeability in the development and progression of liver diseasesExperimental and Clinical Gastroenterology 2023; (12): 130 doi: 10.31146/1682-8658-ecg-220-12-130-139
38
Maria Victoria Fernandez-Cantos, Diego Garcia-Morena, Valeria Iannone, Hani El-Nezami, Marjukka Kolehmainen, Oscar P. Kuipers. Role of microbiota and related metabolites in gastrointestinal tract barrier function in NAFLDTissue Barriers 2021; 9(3) doi: 10.1080/21688370.2021.1879719
39
Lijun Xue, Kaimin Li, Yanfei Jia, Dongxue Yao, Xuexing Guo, Shuhong Zhang. Impact of High-Temperature Feeds on Gut Microbiota and MAFLDJournal of Microbiology and Biotechnology 2024; 34(9): 1789 doi: 10.4014/jmb.2405.05023
40
Doina Georgescu, Oana-Elena Ancusa, Daniel Azoulay, Ana Lascu, Ioana Ionita, Despina Calamar-Popovici, Mihai Ionita, Ciprian Ilie Rosca, Gelu-Mihai Brează, Daniela Reisz, Daniel Lighezan. Portal Vein Thrombosis in Patients with Liver Cirrhosis: What Went Wrong?International Journal of General Medicine 2023; : 3889 doi: 10.2147/IJGM.S413438
41
Jeonghyeon Kwon, Chungho Lee, Sungbaek Heo, Bobae Kim, Chang-Kee Hyun. DSS-induced colitis is associated with adipose tissue dysfunction and disrupted hepatic lipid metabolism leading to hepatosteatosis and dyslipidemia in miceScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-84761-1
42
Xuehua An, Ruike Wang, Chong Cao, Dou Wang, Chen Chen, Yanhua Wang. Synergistic risk in the gut and liver: Insights into the toxic mechanisms and molecular interactions of combined exposure to triazophos and fenvalerate in zebrafishScience of The Total Environment 2024; 948: 174710 doi: 10.1016/j.scitotenv.2024.174710
43
Kexin Tao, Han Peng, Xin Bi, Xiaoya Wang, Yue Tian, Hua Zhang, Yong Sun. Effect of Tetrastigma hemsleyanum leaves and Extract supplementation on liver metabolomics and the gut microbiota in alcohol-induced liver injuryFood Bioscience 2024; 58: 103617 doi: 10.1016/j.fbio.2024.103617
44
Joanna K. Hodges, Geoffrey Y. Sasaki, Richard S. Bruno. Anti-inflammatory activities of green tea catechins along the gut–liver axis in nonalcoholic fatty liver disease: lessons learned from preclinical and human studiesThe Journal of Nutritional Biochemistry 2020; 85: 108478 doi: 10.1016/j.jnutbio.2020.108478
45
A. S. Ostrovskaya, M. V. Maevskaya. Sarcopenia and malnutrition in patients with liver diseasesMeditsinskiy sovet = Medical Council 2023; (18): 35 doi: 10.21518/ms2023-374
46
Galit Weinstein, Yochai Schonmann, Hanny Yeshua, Shira Zelber‐Sagi. The association between liver fibrosis score and incident dementia: A nationwide retrospective cohort studyAlzheimer's & Dementia 2024; 20(8): 5385 doi: 10.1002/alz.14033
47
Susana G. Rodrigues, Schalk van der Merwe, Aleksander Krag, Reiner Wiest. Gut-liver axis: Pathophysiological concepts and medical perspective in chronic liver diseasesSeminars in Immunology 2024; 71: 101859 doi: 10.1016/j.smim.2023.101859
48
Jie‐Lun Ku, Jia‐Rou Hsu, Yung‐Tsung Li, Li‐Ling Wu. Interplay among IL1R1, gut microbiota, and bile acids in metabolic dysfunction‐associated steatotic liver disease: a comprehensive reviewJournal of Gastroenterology and Hepatology 2024;  doi: 10.1111/jgh.16750
49
Toon J.I. De Munck, Pauline Verhaegh, Corinne Spooren, Zlatan Mujagic, Tobias Wienhold, Daisy Jonkers, Ad A.M. Masclee, Ger H. Koek, Jef Verbeek. Colonic permeability is increased in non-cirrhotic patients with nonalcoholic fatty liver diseaseDigestive and Liver Disease 2023; 55(5): 614 doi: 10.1016/j.dld.2022.12.022
50
Shynggys Sergazy, Zarina Shulgau, Yevgeniy Kamyshanskiy, Zhaxybay Zhumadilov, Elena Krivyh, Alexander Gulyayev, Mohamad Aljofan. Blueberry and cranberry extracts mitigate CCL4-induced liver damage, suppressing liver fibrosis, inflammation and oxidative stressHeliyon 2023; 9(4): e15370 doi: 10.1016/j.heliyon.2023.e15370
51
Francesca Romana Ponziani, Gaetano Coppola, Pierluigi Rio, Mario Caldarelli, Raffaele Borriello, Giovanni Gambassi, Antonio Gasbarrini, Rossella Cianci. Factors Influencing Microbiota in Modulating Vaccine Immune Response: A Long Way to GoVaccines 2023; 11(10): 1609 doi: 10.3390/vaccines11101609
52
Syeda Tasnim Quayum, Nusrat Jahan Ikbal Esha, Siam Siraji, Sanaa S. Al Abbad, Zainab H.A. Alsunaidi, Mansour H. Almatarneh, Shofiur Rahman, Abdullah N. Alodhayb, Khuloud A. Alibrahim, Sarkar M.A. Kawsar, Kabir M. Uddin. Exploring the effectiveness of flavone derivatives for treating liver diseases: Utilizing DFT, molecular docking, and molecular dynamics techniquesMethodsX 2024; 12: 102537 doi: 10.1016/j.mex.2023.102537
53
Kanav Kaushal, Samagra Agarwal, Sanchit Sharma, Pooja Goswami, Namrata Singh, Vikas Sachdev, Shekhar Poudel, Prasenjit Das, Rajni Yadav, Dinesh Kumar, Gaurav Pandey, Deepak Gunjan, Anoop Saraya. Demonstration of Gut-Barrier Dysfunction in Early Stages of Non-alcoholic Fatty Liver Disease: A Proof-Of-Concept StudyJournal of Clinical and Experimental Hepatology 2022; 12(4): 1102 doi: 10.1016/j.jceh.2022.01.006
54
Raquel Benedé-Ubieto, Francisco Javier Cubero, Yulia A. Nevzorova. Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD)Gut Microbes 2024; 16(1) doi: 10.1080/19490976.2024.2331460
55
Irina Efremova, Roman Maslennikov, Maria Zharkova, Elena Poluektova, Nona Benuni, Aleksandr Kotusov, Tatyana Demina, Aleksandra Ivleva, Farida Adzhieva, Taisiya Krylova, Vladimir Ivashkin. Efficacy and Safety of a Probiotic Containing Saccharomyces boulardii CNCM I-745 in the Treatment of Small Intestinal Bacterial Overgrowth in Decompensated Cirrhosis: Randomized, Placebo-Controlled StudyJournal of Clinical Medicine 2024; 13(3): 919 doi: 10.3390/jcm13030919
56
Francesco Santopaolo, Gaetano Coppola, Lucia Giuli, Antonio Gasbarrini, Francesca Romana Ponziani. Influence of Gut–Liver Axis on Portal Hypertension in Advanced Chronic Liver Disease: The Gut Microbiome as a New Protagonist in Therapeutic ManagementMicrobiology Research 2022; 13(3): 539 doi: 10.3390/microbiolres13030038
57
Marta Maestri, Francesco Santopaolo, Maurizio Pompili, Antonio Gasbarrini, Francesca Romana Ponziani. Gut microbiota modulation in patients with non-alcoholic fatty liver disease: Effects of current treatments and future strategiesFrontiers in Nutrition 2023; 10 doi: 10.3389/fnut.2023.1110536
58
Nasrin Mehranfard, Azadeh Yazdi, Asiye Rafiee Sardooi, Zeinab Shakerin, Maedeh Ghasemi. Honey protects against chronic unpredictable mild stress induced- intestinal barrier disintegration and hepatic inflammationMolecular Biology Reports 2020; 47(11): 8475 doi: 10.1007/s11033-020-05888-4
59
Ludovico ABENAVOLI, Anna C. PROCOPIO, Emidio SCARPELLINI, Natale POLIMENI, Isabella AQUILA, Tiziana LARUSSA, Luigi BOCCUTO, Francesco LUZZA. Gut microbiota and non-alcoholic fatty liver diseaseMinerva Gastroenterology 2022; 67(4) doi: 10.23736/S2724-5985.21.02896-5
60
Subhamay Adhikary, Akanksha Esmeeta, Amit Dey, Antara Banerjee, Biki Saha, Pournami Gopan, Asim K. Duttaroy, Surajit Pathak. Impacts of gut microbiota alteration on age-related chronic liver diseasesDigestive and Liver Disease 2024; 56(1): 112 doi: 10.1016/j.dld.2023.06.017
61
Guole Nie, Honglong Zhang, Danna Xie, Jun Yan, Xun Li. Liver cirrhosis and complications from the perspective of dysbiosisFrontiers in Medicine 2024; 10 doi: 10.3389/fmed.2023.1320015
62
Shuang Gao, Muhammad Imran Khan, Fadia Kalsoom, Zhen Liu, Yanxin Chen, Zhengli Chen. Role of gene regulation and inter species interaction as a key factor in gut microbiota adaptationArchives of Microbiology 2022; 204(6) doi: 10.1007/s00203-022-02935-5
63
Mauro Giuffrè, Michele Campigotto, Giuseppina Campisciano, Manola Comar, Lory Saveria Crocè. A story of liver and gut microbes: how does the intestinal flora affect liver disease? A review of the literatureAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2020; 318(5): G889 doi: 10.1152/ajpgi.00161.2019
64
Roman Maslennikov, Vladimir Ivashkin, Irina Efremova, Elena Poluektova, Elena Shirokova. Gut-liver axis in cirrhosis: Are hemodynamic changes a missing link?World Journal of Clinical Cases 2021; 9(31): 9320-9332 doi: 10.12998/wjcc.v9.i31.9320
65
Winston Hernández-Ceballos, Jacqueline Cordova-Gallardo, Nahum Mendez-Sanchez. Gut Microbiota in Metabolic-associated Fatty Liver Disease and in Other Chronic Metabolic DiseasesJournal of Clinical and Translational Hepatology 2021; 0(000): 000 doi: 10.14218/JCTH.2020.00131
66
Suling Zeng, Bernd Schnabl. Roles for the mycobiome in liver diseaseLiver International 2022; 42(4): 729 doi: 10.1111/liv.15160
67
Damien Chua, Zun Siong Low, Guo Xiang Cheam, Aik Seng Ng, Nguan Soon Tan. Utility of Human Relevant Preclinical Animal Models in Navigating NAFLD to MAFLD ParadigmInternational Journal of Molecular Sciences 2022; 23(23): 14762 doi: 10.3390/ijms232314762
68
Mohamad Jamalinia, Amedeo Lonardo, Ralf Weiskirchen. Sex and Gender Differences in Liver Fibrosis: Pathomechanisms and Clinical OutcomesFibrosis 2024; 2(1): 10006 doi: 10.70322/fibrosis.2024.10006
69
Stefania Del Fabbro, Philip C. Calder, Caroline E. Childs. Microbiota-independent immunological effects of non-digestible oligosaccharides in the context of inflammatory bowel diseasesProceedings of the Nutrition Society 2020; 79(4): 468 doi: 10.1017/S0029665120006953
70
Fernando Vidal-Vanaclocha, Olatz Crende, Cira García de Durango, Alejandro Herreros-Pomares, Sandra López-Doménech, Álvaro González, Eva Ruiz-Casares, Thierry Vilboux, Riccardo Caruso, Hipólito Durán, Antonio Gil, Benedetto Ielpo, Fernando Lapuente, Yolanda Quijano, Emilio Vicente, Leticia Vidal-Lartitegui, Eduardo M. Sotomayor. Liver prometastatic reaction: Stimulating factors and responsive cancer phenotypesSeminars in Cancer Biology 2021; 71: 122 doi: 10.1016/j.semcancer.2020.08.001
71
Leonard Kaps, Carolina Medina-Montano, Matthias Bros, Stephan Grabbe, Simon Johannes Gairing, Eva M. Schleicher, Stephan Gehring, Jörn M. Schattenberg, Peter R. Galle, Marcus-Alexander Wörns, Michael Nagel, Christian Labenz, Tomasz Brzozowski. Comparison of Inflammatory Cytokine Levels in Hepatic and Jugular Veins of Patients with CirrhosisMediators of Inflammation 2023; 2023: 1 doi: 10.1155/2023/9930902
72
Mattia Paratore, Francesco Santopaolo, Giovanni Cammarota, Maurizio Pompili, Antonio Gasbarrini, Francesca Romana Ponziani. Fecal Microbiota Transplantation in Patients with HBV Infection or Other Chronic Liver Diseases: Update on Current Knowledge and Future PerspectivesJournal of Clinical Medicine 2021; 10(12): 2605 doi: 10.3390/jcm10122605
73
Tope Oyelade, Kevin P. Moore, Ali R. Mani. Physiological network approach to prognosis in cirrhosis: A shifting paradigmPhysiological Reports 2024; 12(13) doi: 10.14814/phy2.16133
74
Osamu Yoshino. Postinjury Multiple Organ FailureHot Topics in Acute Care Surgery and Trauma 2022; : 133 doi: 10.1007/978-3-030-92241-2_13
75
Eamonn M. M. Quigley. Liver Immunology2020; : 125 doi: 10.1007/978-3-030-51709-0_8
76
Cheng Zhao, Xiaoming Kao, Zhiwei Wang, Qinjie Liu, Jie Wu, Qiongyuan Hu, Xiuwen Wu, Jianan Ren. Biomimetic enzyme barrier for preventing intestine-derived LPS induced diseasesRSC Advances 2020; 10(15): 9126 doi: 10.1039/C9RA08721D
77
Yifan Guo, Lin Chang, Ge Zhang, Zhanyan Gao, Hao Lin, Yuting Zhang, Liang Hu, She Chen, Bing Fan, Si Zhang, Ruyi Xue. The role of Sphingomyelin synthase 2 (SMS2) in platelet activation and its clinical significanceThrombosis Journal 2021; 19(1) doi: 10.1186/s12959-021-00282-x
78
Nicolás Ortiz-López, Catalina Fuenzalida, María Soledad Dufeu, Araceli Pinto-León, Alejandro Escobar, Jaime Poniachik, Juan Pablo Roblero, Lucía Valenzuela-Pérez, Caroll J. Beltrán. The immune response as a therapeutic target in non-alcoholic fatty liver diseaseFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.954869
79
Asra tus Saleha Siddiqui, Om Parkash, Syeda Amrah Hashmi. Malnutrition and liver disease in a developing countryWorld Journal of Gastroenterology 2021; 27(30): 4985-4998 doi: 10.3748/wjg.v27.i30.4985
80
Irina Efremova, Roman Maslennikov, Elena Poluektova, Oleg Medvedev, Anna Kudryavtseva, George Krasnov, Maria Fedorova, Filipp Romanikhin, Vyacheslav Bakhitov, Salekh Aliev, Natalia Sedova, Tatiana Kuropatkina, Anastasia Ivanova, Maria Zharkova, Ekaterina Pervushova, Vladimir Ivashkin. Gut Microbiota and Biomarkers of Endothelial Dysfunction in CirrhosisInternational Journal of Molecular Sciences 2024; 25(4): 1988 doi: 10.3390/ijms25041988
81
Roman Maslennikov, Aliya Alieva, Elena Poluektova, Yury Zharikov, Andrey Suslov, Yana Letyagina, Ekaterina Vasileva, Anna Levshina, Evgenii Kozlov, Vladimir Ivashkin. Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiotaWorld Journal of Gastroenterology 2023; 29(27): 4236-4251 doi: 10.3748/wjg.v29.i27.4236
82
Piero Portincasa, Leonilde Bonfrate, Mohamad Khalil, Maria De Angelis, Francesco Maria Calabrese, Mauro D’Amato, David Q.-H. Wang, Agostino Di Ciaula. Intestinal Barrier and Permeability in Health, Obesity and NAFLDBiomedicines 2021; 10(1): 83 doi: 10.3390/biomedicines10010083
83
Roberta Forlano, Giordano Sigon. A two-sample Mendelian randomization study to identity microbiome signatures in patients with Non-alcoholic fatty liver diseaseDigestive and Liver Disease 2023; 55(11): 1462 doi: 10.1016/j.dld.2023.07.029
84
Luoyi Zhu, Xin Zong, Xiao Xiao, Yuanzhi Cheng, Jie Fu, Zeqing Lu, Mingliang Jin, Fengqin Wang, Yizhen Wang. Multi-Omics Analysis of the Gut-Liver Axis Reveals the Mechanism of Liver Injury in Colitis MiceFrontiers in Immunology 2022; 12 doi: 10.3389/fimmu.2021.773070
85
So Yeong Cheon, Juhyun Song. Novel insights into non-alcoholic fatty liver disease and dementia: insulin resistance, hyperammonemia, gut dysbiosis, vascular impairment, and inflammationCell & Bioscience 2022; 12(1) doi: 10.1186/s13578-022-00836-0
86
Kylynda C. Bauer, Paula T. Littlejohn, Victoria Ayala, Anna Creus-Cuadros, B. Brett Finlay. Nonalcoholic Fatty Liver Disease and the Gut-Liver Axis: Exploring an Undernutrition PerspectiveGastroenterology 2022; 162(7): 1858 doi: 10.1053/j.gastro.2022.01.058
87
Salvatore Pezzino, Maria Sofia, Gloria Faletra, Chiara Mazzone, Giorgia Litrico, Gaetano La Greca, Saverio Latteri. Gut–Liver Axis and Non-Alcoholic Fatty Liver Disease: A Vicious Circle of Dysfunctions Orchestrated by the Gut MicrobiomeBiology 2022; 11(11): 1622 doi: 10.3390/biology11111622
88
Lucia Cerrito, Francesco Santopaolo, Flavia Monti, Maurizio Pompili, Antonio Gasbarrini, Francesca Romana Ponziani. Advances in pharmacotherapeutics for hepatocellular carcinomaExpert Opinion on Pharmacotherapy 2021; 22(10): 1343 doi: 10.1080/14656566.2021.1892074
89
Zhiqiang Yan, Fang Yang, Zhu Hong, Shishun Wang, Zhang Jinjuan, Bing Han, Rujia Xie, Feiyun Leng, Qin Yang. Blueberry Attenuates Liver Fibrosis, Protects Intestinal Epithelial Barrier, and Maintains Gut Microbiota HomeostasisCanadian Journal of Gastroenterology and Hepatology 2019; 2019: 1 doi: 10.1155/2019/5236149
90
Marc Micó-Carnero, Carlos Rojano-Alfonso, Ana Isabel Álvarez-Mercado, Jordi Gracia-Sancho, Araní Casillas-Ramírez, Carmen Peralta. Effects of Gut Metabolites and Microbiota in Healthy and Marginal Livers Submitted to SurgeryInternational Journal of Molecular Sciences 2020; 22(1): 44 doi: 10.3390/ijms22010044
91
Swadha Anand, Sharmila S. Mande. Host-microbiome interactions: Gut-Liver axis and its connection with other organsnpj Biofilms and Microbiomes 2022; 8(1) doi: 10.1038/s41522-022-00352-6
92
Roberta Forlano, Benjamin H. Mullish, Lauren A. Roberts, Mark R. Thursz, Pinelopi Manousou. The Intestinal Barrier and Its Dysfunction in Patients with Metabolic Diseases and Non-Alcoholic Fatty Liver DiseaseInternational Journal of Molecular Sciences 2022; 23(2): 662 doi: 10.3390/ijms23020662
93
Agostino Di Ciaula, Jacek Baj, Gabriella Garruti, Giuseppe Celano, Maria De Angelis, Helen H. Wang, Domenica Maria Di Palo, Leonilde Bonfrate, David Q-H Wang, Piero Portincasa. Liver Steatosis, Gut-Liver Axis, Microbiome and Environmental Factors. A Never-Ending Bidirectional Cross-TalkJournal of Clinical Medicine 2020; 9(8): 2648 doi: 10.3390/jcm9082648
94
Yifei Zou, Xianjing Song, Ning Liu, Wei Sun, Bin Liu. Intestinal Flora: A Potential New Regulator of Cardiovascular DiseaseAging and disease 2022; 13(3): 753 doi: 10.14336/AD.2021.1022
95
Reem Z. Sharaiha, Scott Shikora, Kevin P. White, Guilherme Macedo, Jim Toouli, Lillian Kow. Summarizing Consensus Guidelines on Obesity ManagementJournal of Clinical Gastroenterology 2023; 57(10): 967 doi: 10.1097/MCG.0000000000001916
96
A. S. Ostrovskaya, M. V. Maevskaya, K. M. Loban, M. S. Zharkova, M. P. Shapka, M. Yu. Nadinskaia, K. A. Gulyaeva, E. A. Vasiltsova, Yu. O. Chvileva, V. T. Ivashkin. Upper limb SMI for sarcopenia diagnosis in liver cirrhosisMeditsinskiy sovet = Medical Council 2024; (15): 126 doi: 10.21518/ms2024-382
97
Naila Shoaib, Zaman Khan, Marukh Ibrahim, Anjam Hafeez, Arooj Fatima, Hassan Imran, Fiza Saleem, Syed Muhammad Hassan Askari, Sidra Gull. Dyslipidemia and impaired liver function biomarkers in patients with hepatitis B liver cirrhosisJournal of Taibah University Medical Sciences 2023; 18(4): 748 doi: 10.1016/j.jtumed.2023.01.002
98
I. A. Krylova, A. V. Lyamin, V. I. Kupaev. Clinical improvement of some indicators of the activity of non-alcoholic fatty liver disease after correction of intestinal dysbiosis with dietary fiberExperimental and Clinical Gastroenterology 2024; (2): 44 doi: 10.31146/1682-8658-ecg-222-2-44-49
99
Roman Maslennikov, Irina Efremova, Vladimir Ivashkin, Maria Zharkova, Elena Poluektova, Elena Shirokova, Konstantin Ivashkin. Effect of probiotics on hemodynamic changes and complications associated with cirrhosis: A pilot randomized controlled trialWorld Journal of Hepatology 2022; 14(8): 1667-1677 doi: 10.4254/wjh.v14.i8.1667
100
Domenica Maria Di Palo, Gabriella Garruti, Agostino Di Ciaula, Emilio Molina-Molina, Harshitha Shanmugam, Maria De Angelis, Piero Portincasa. Increased Colonic Permeability and Lifestyles as Contributing Factors to Obesity and Liver SteatosisNutrients 2020; 12(2): 564 doi: 10.3390/nu12020564
101
Federica Di Vincenzo, Alberto Nicoletti, Marcantonio Negri, Federica Vitale, Lorenzo Zileri Dal Verme, Antonio Gasbarrini, Francesca Romana Ponziani, Lucia Cerrito. Gut Microbiota and Antibiotic Treatments for the Main Non-Oncologic Hepato-Biliary-Pancreatic DisordersAntibiotics 2023; 12(6): 1068 doi: 10.3390/antibiotics12061068
102
Li Zhang, Zhiyi Zheng, Huanhuan Huang, Ya Fu, Tianbin Chen, Can Liu, Qiang Yi, Caorui Lin, Yongjun Zeng, Qishui Ou, Yongbin Zeng. Multi-omics reveals deoxycholic acid modulates bile acid metabolism via the gut microbiota to antagonize carbon tetrachloride-induced chronic liver injuryGut Microbes 2024; 16(1) doi: 10.1080/19490976.2024.2323236
103
Darrick K. Li, Snehal N. Chaudhari, Yoojin Lee, Mozhdeh Sojoodi, Arijit A. Adhikari, Lawrence Zukerberg, Stuti Shroff, Stephen Cole Barrett, Kenneth Tanabe, Raymond T. Chung, A. Sloan Devlin. Inhibition of microbial deconjugation of micellar bile acids protects against intestinal permeability and liver injuryScience Advances 2022; 8(34) doi: 10.1126/sciadv.abo2794
104
Lucia Giuli, Marta Maestri, Francesco Santopaolo, Maurizio Pompili, Francesca Romana Ponziani. Gut Microbiota and Neuroinflammation in Acute Liver Failure and Chronic Liver DiseaseMetabolites 2023; 13(6): 772 doi: 10.3390/metabo13060772
105
Camila Marques de Alcântara Barreto, Eliane Almeida do Valle, Jessica Pronestino de Lima Moreira, Katia Farias e Silva, Siane Lopes Bittencourt Rosas, Patrícia Teixeira Santana, Ana Maria Pittella, Gustavo Pereira, Flavia Ferreira Fernandes, Renata de Mello Perez, Heitor Siffert Pereira de Souza. Gut-related molecules as potential biomarkers in patients with decompensated cirrhosisAnnals of Hepatology 2025; 30(1): 101567 doi: 10.1016/j.aohep.2024.101567
106
Igor G. Bakulin, Inna A. Oganezova, Maria I. Skalinskaya, Ekaterina V. Skazyvaeva. Liver cirrosis and complication risk managementTerapevticheskii arkhiv 2021; 93(8): 963 doi: 10.26442/00403660.2021.08.200917
107
Carlo Smirne, Eleonora Croce, Davide Di Benedetto, Vincenzo Cantaluppi, Cristoforo Comi, Pier Paolo Sainaghi, Rosalba Minisini, Elena Grossini, Mario Pirisi. Oxidative Stress in Non-Alcoholic Fatty Liver DiseaseLivers 2022; 2(1): 30 doi: 10.3390/livers2010003
108
Montserrat Rodríguez-Ayala, Carolina Donat-Vargas, Belén Moreno-Franco, Diana María Mérida, José Ramón Banegas, Fernando Rodríguez-Artalejo, Pilar Guallar-Castillón. Association of a healthy beverage score with total mortality in the adult population of Spain: A nationwide cohort studyPLOS Medicine 2024; 21(1): e1004337 doi: 10.1371/journal.pmed.1004337
109
Caterina Conte. Thyroid, Obesity and Metabolism2021; : 95 doi: 10.1007/978-3-030-80267-7_7